Skip to main content
. 2023 Jun 21;15(6):e40719. doi: 10.7759/cureus.40719

Table 1. Summary of search strategy used in our review.

Keywords Medical subject headings (Mesh) Query strings Final Search Term-Combining query strings with Boolean logical operators
Belimumab OR B cell depleting agents "belimumab" [Supplementary Concept] Belimumab OR B cell depleting agents OR"belimumab" [Supplementary Concept] Belimumab OR B cell depleting agents OR"belimumab" [Supplementary Concept] OR RITUXIMAB OR cd20 antibody OR (“Rituximab/adverse effects"[Mesh] OR “Rituximab/drug effects"[Mesh] OR “Rituximab/therapeutic use"[Mesh] ) AND Systemic lupus Erythematosus OR "Lupus Erythematosus, Systemic/drug therapy"[Majr]
RITUXIMAB OR Cd20 antibody (“Rituximab/adverse effects"[Mesh] OR “Rituximab/drug effects"[Mesh] OR  "Rituximab/therapeutic use"[Mesh] RITUXIMAB OR anti cd20 antibody OR (“Rituximab/adverse effects"[Mesh] OR “Rituximab/drug effects"[Mesh] OR “Rituximab/therapeutic use"[Mesh]
Systemic Lupus Erythematosus ("Lupus Erythematosus, Systemic/drug therapy"[Mesh] OR  "Lupus Erythematosus, Systemic/therapy"[Mesh] Systemic Lupus Erythematosus OR "Lupus Erythematosus, Systemic/drug therapy"[Majr]